Drilling Down Into InnSuites Hospitality Trust (IHT)

InnSuites Hospitality Trust (IHT) is an interesting player in the Financial space, with a focus on REIT – Hotel/Motel. The stock has been active on the tape, currently trading at $2.27, up from yesterday’s close by 34.33%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.

Fundamental Analysis

InnSuites Hospitality Trust (IHT) currently trades with a market capitalization of $22.18 Million. That value represents a market adjusting for revenues that have been growing by 28.32 % on a quarterly year/year basis as of the company’s last quarterly report.

You can get a sense of how sustainable that is by a levered free cash flow of -$3.34 Million over the past twelve months. Generally speaking, earnings are expected to hold steady in coming quarters. Analysts are forecasting earnings of $0 on a per share basis this quarter. Perhaps, that suggests something about why 75.16% of the outstanding share supply is held by institutional investors.

Technical Analysis

No analysis is ever complete without a thorough survey of a stock’s technical behavior. Looking at the stock’s movement on the chart, InnSuites Hospitality Trust recorded a 52-week high of $2.27. It is now trading 0% off that level. The stock is trading $1.62 its 50-day moving average by -0.65%. The stock carved out a 52-week low down at $1.23.

In recent action, InnSuites Hospitality Trust (IHT) has made a move of +50.33% over the past month, which has come on weak relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 14.61, and it’s gotten there by action that has been less volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 0.20% with $2.31 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of IHT.

Previous articleAbercrombie & Fitch Co. (ANF): From Top to Bottom
Next articleThe Case for and Against Abbott Laboratories (ABT)